ClinicalTrials.gg
Sign In

Leukemia, Myeloid clinical trials

The registry lists 136 studies for Leukemia, Myeloid across more than 10 countries. 23 are recruiting or about to start. 36 of them are mainly about Leukemia, Myeloid (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03. Counting its 16 narrower conditions too, such as Leukemia, Myeloid, Acute: 4,757 studies, 960 open.

Get an email when these change. Save the Leukemia, Myeloid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
64
Terminated
24
Recruiting
19
Status unknown
16
Active, not recruiting
6
Not yet recruiting
4

Phase

Phase 1
54
Phase 2
53
Phase 3
15
Early Phase 1
5

Where

United States
85
France
21
Germany
17
Canada
16
China
15
Spain
14

Who runs them

M.D. Anderson Cancer Center (7) · Ariad Pharmaceuticals (4) · Novartis Pharmaceuticals (4) · Celgene (4) · University of Colorado, Denver (3) · AbbVie (3) · Dana-Farber Cancer Institute (3) · National Heart, Lung, and Blood Institute (NHLBI) (3)

What is being tested here

Drugs under test in Leukemia, Myeloid studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Venetoclax508
Fludarabine207
Cyclophosphamide105
Cytarabine105
Asciminib103
Azacitidine103
Mycophenolic Acid102
Interleukin-2102
Autologous Anti-CD123 CAR-T Cells102
Idarubicin101

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 3 open · Antimetabolites 3 open · Alkylating agents 1 open

Coming up

1phase 3 study under way
10studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10

Who these studies take

Of the 19 Leukemia, Myeloid studies recruiting now, 10 (53%) set no upper age limit and 7 (37%) stop at 75 or younger. 5 (26%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
104 (21%)4 (21%)
1818 (95%)18 (95%)
3018 (95%)18 (95%)
4017 (89%)17 (89%)
5018 (95%)18 (95%)
6518 (95%)18 (95%)
7515 (79%)15 (79%)
8511 (58%)11 (58%)

Across all 136 studies, recruiting or not: 29% stop at 75 or younger and 15% at 65; 22% take children; 1% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Leukemia, Myeloid studies take

Of 24 phase 1 interventional studies under Leukemia, Myeloid, half reached primary completion within 48 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 148 mo30–74 · 24 studies——
Phase 248 mo36–72 · 18 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 136. Browse all 136 → or search them.